Carotenoids (Table 1) have been shown to modulate obesity-associated inflammation, atherosclerosis, and CVD through ameliorating the IGF-1, IL-1β, IL-6, and MCP-1 signals (Beukes et al., 2014). Here, IL6 is linked to obesity disorder.